Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Operating Expenses (2010 - 2026)

Exelixis (EXEL) posted quarterly Operating Expenses of $359.5 million for Q2 2026, down 2.47% year-over-year from $368.6 million in Q2 2025, and down 1.09% quarter-over-quarter from $363.4 million in Q1 2026.

Analysis

Exelixis (EXEL) Operating Expenses (2010 - 2026) Analysis & Trends

Exelixis' Operating Expenses history runs 17 years deep, the most recent figure standing at $359.5 million for Q2 2026.

  • In Q2 2026, Operating Expenses fell 2.47% year-over-year to $359.5 million; the TTM figure through Apr 2026 stood at $1.4 billion (down 6.38% YoY), while the FY2026 annual figure was $1.4 billion, down 7.43% from the prior year.
  • Operating Expenses for Q2 2026 stood at $359.5 million, down from $363.4 million in the prior quarter.
  • The five-year high for Operating Expenses was $489.5 million in Q3 2023, with the low at $272.7 million in Q2 2022.
  • The 5-year median for Operating Expenses is $368.6 million (2025), against an average of $378.8 million.
  • The sharpest annual moves came in 2023 and 2024: Operating Expenses surged 48.73% in 2023, then retreated 17.58% in 2024.
  • Exelixis' Operating Expenses stood at $472.0 million in 2022, then fell by 15.71% to $397.9 million in 2023, then rose by 1.41% to $403.5 million in 2024, then decreased by 10.47% to $361.2 million in 2025, then declined by 0.48% to $359.5 million in 2026.
  • Business Quant data shows EXEL's Operating Expenses at $359.5 million in Q2 2026, $363.4 million in Q1 2026, and $361.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 2.09 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 3.00 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.05 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 960.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.21 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.06 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 541.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 427.03 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 380.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 380.28 Mn
Apr 3, 2026 359.47 Mn
Jan 2, 2026 363.45 Mn
Oct 3, 2025 361.22 Mn
Jul 4, 2025 354.69 Mn
Apr 4, 2025 368.59 Mn
Jan 3, 2025 403.55 Mn
Sep 27, 2024 403.47 Mn
Jun 28, 2024 361.30 Mn
Mar 29, 2024 395.76 Mn
Dec 29, 2023 397.86 Mn
Sep 29, 2023 489.50 Mn
Jun 30, 2023 392.00 Mn
Mar 31, 2023 379.96 Mn
Dec 30, 2022 472.00 Mn
Sep 30, 2022 329.13 Mn
Jul 1, 2022 335.72 Mn
Apr 1, 2022 272.74 Mn
Dec 31, 2021 334.50 Mn
Oct 1, 2021 276.80 Mn